FDA recall Z-2753-2020

RANDOX LABORATORIES, LTD. · Class II · device

Product

Randox Lipase Assay: Lipase Colorimetric R2 Substrate - Product Usage: A Lipase test system is a device intended for the quantitative in vitro determination of Lipase in human serum and plasma.

Reason for recall

Randox have confirmed imprecision of quality control and patient samples when using specific Randox Lipase R2 Substrate batches.

Distribution

Worldwide distribution - US Nationwide distribution including in the states of Puerto Rico and WV.

Key facts

Status
Terminated
Initiation date
2020-06-26
Report date
2020-08-12
Termination date
2020-10-19
Voluntary/Mandated
Voluntary: Firm initiated
Location
Crumlin Colorado Antrim, United Kingdom

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2753-2020